Table 2.
Characteristics of patients with muscle-invasive TCC of the bladder.
| Patient number | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| Age at transplant | 38 | 58 | 60 | 66 |
| Type of transplant | Renal | Liver | Renal | Renal |
| Age at diagnosis | 44 | 60 | 63 | 70 |
| Immunosuppression | FK, Pred | FK, MMF, Pred | FK, Pred | FK, Pred |
| Pathologic stage | T3aN0M0 | T3N2M0 | T2N0M0 | T2N0M1 |
| Histology | TCC, CIS | TCC | TCC | TCC |
| Grade | High | High | High | High |
| Treatment | Cystectomy, allograft nephrostomy | Cystectomy, neobladder | Palliative XRT, Ileal conduit | Palliative XRT |
| Followup (months) | 24 | 36 | 16 | 12 |
| Metastasis (months) | None | None | None | Liver, pulmonary (12) |
| Status | Alive | Alive | Deceased (DIC) | Deceased |
FK: tacrolimus; MMF: mycophenolate mofetil; Pred: prednisone; CIS: carcinoma in site; TURBT: transurethral resection of bladder tumor; DIC: disseminated intravascular coagulation; XRT: external beam radiotherapy.